 Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
| Descriptor ID |
D003131
|
| MeSH Number(s) |
E02.186
|
| Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 0 | 47 | 47 | | 1990 | 0 | 58 | 58 | | 1991 | 0 | 62 | 62 | | 1992 | 0 | 53 | 53 | | 1993 | 0 | 59 | 59 | | 1994 | 0 | 93 | 93 | | 1995 | 0 | 84 | 84 | | 1996 | 0 | 81 | 81 | | 1997 | 0 | 74 | 74 | | 1998 | 1 | 82 | 83 | | 1999 | 0 | 98 | 98 | | 2000 | 1 | 102 | 103 | | 2001 | 3 | 106 | 109 | | 2002 | 0 | 119 | 119 | | 2003 | 1 | 159 | 160 | | 2004 | 1 | 160 | 161 | | 2005 | 0 | 162 | 162 | | 2006 | 1 | 176 | 177 | | 2007 | 2 | 171 | 173 | | 2008 | 1 | 172 | 173 | | 2009 | 2 | 167 | 169 | | 2010 | 2 | 178 | 180 | | 2011 | 4 | 151 | 155 | | 2012 | 1 | 124 | 125 | | 2013 | 7 | 141 | 148 | | 2014 | 2 | 133 | 135 | | 2015 | 4 | 149 | 153 | | 2016 | 7 | 180 | 187 | | 2017 | 6 | 157 | 163 | | 2018 | 5 | 110 | 115 | | 2019 | 0 | 15 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Park JR, Kreissman SG, London WB, Naranjo A, Cohn SL, Hogarty MD, Tenney SC, Haas-Kogan D, Shaw PJ, Kraveka JM, Roberts SS, Geiger JD, Doski JJ, Voss SD, Maris JM, Grupp SA, Diller L. Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial. JAMA. 2019 08 27; 322(8):746-755.
-
Zhao B, Tsai C, Hunt KK, Blair SL. Adherence to surgical and oncologic standards improves survival in breast cancer patients. J Surg Oncol. 2019 Aug; 120(2):148-159.
-
Balasubramanyam S, O'Donnell BP, Musher BL, Jhaveri PM, Ludwig MS. Evaluating Treatment Patterns for Small Cell Carcinoma of the Colon Using the National Cancer Database (NCDB). J Gastrointest Cancer. 2019 Jun; 50(2):244-253.
-
Rodon J, Soria JC, Berger R, Miller WH, Rubin E, Kugel A, Tsimberidou A, Saintigny P, Ackerstein A, Braña I, Loriot Y, Afshar M, Miller V, Wunder F, Bresson C, Martini JF, Raynaud J, Mendelsohn J, Batist G, Onn A, Tabernero J, Schilsky RL, Lazar V, Lee JJ, Kurzrock R. Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial. Nat Med. 2019 05; 25(5):751-758.
-
Abdelfatah MM, Gochanour E, Koutlas NJ, Othman MO. Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Single Versus Dual Prophylactic Modalities. Pancreas. 2019 04; 48(4):e24.
-
Fu LH, Qi C, Hu YR, Lin J, Huang P. Glucose Oxidase-Instructed Multimodal Synergistic Cancer Therapy. Adv Mater. 2019 May; 31(21):e1808325.
-
Ferguson SD, Bindal S, Bassett RL, Haydu LE, McCutcheon IE, Heimberger AB, Li J, O'Brien BJ, Guha-Thakurta N, Tetzlaff MT, Tawbi H, Davies MA, Glitza IC. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol. 2019 May; 142(3):499-509.
-
Collins MS, Miranda RN, Medeiros LJ, Silva de Meneses MP, Iyer SP, Butler CE, Liu J, Clemens MW. Characteristics and Treatment of Advanced Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019 03; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S-50S.
-
Tessler RA, Dellinger M, Richards MK, Goldin AB, Beierle EA, Doski JJ, Goldfarb M, Langer M, Nuchtern JG, Raval MV, Vasudevan S, Gow KW. Pediatric gastric adenocarcinoma: A National Cancer Data Base review. J Pediatr Surg. 2019 May; 54(5):1029-1034.
-
Brooks ED, Chang JY. Time to abandon single-site irradiation for inducing abscopal effects. Nat Rev Clin Oncol. 2019 02; 16(2):123-135.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|